Adocia SA (EPA:ADOC)
France · Delayed Price · Currency is EUR 7.00
+0.02 (0.29%)
At close: Feb 20, 2026
Adocia Market Cap
Adocia has a market cap or net worth of €137.15 million as of February 20, 2026. Its market cap has increased by 61.05% in one year.
Market Cap
137.15M
Enterprise Value
140.53M
Revenue
12.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.00
Market Cap Chart
Since February 20, 2012, Adocia's market cap has increased from 93.74M to 137.15M, an increase of 46.32%. That is a compound annual growth rate of 2.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 137.15M | 4.69% |
| Dec 31, 2025 | 131.01M | 40.99% |
| Dec 31, 2024 | 92.92M | -42.69% |
| Dec 29, 2023 | 162.13M | 379.37% |
| Dec 30, 2022 | 33.82M | -41.93% |
| Dec 31, 2021 | 58.24M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 392.39M |
| Cellectis | 248.80M |
| Transgene | 225.09M |
| MaaT Pharma | 138.87M |
| Innate Pharma | 131.78M |
| ABIONYX Pharma | 118.36M |
| OSE Immunotherapeutics | 96.41M |
| Sensorion | 94.91M |